Key Findings
- The pooled estimate favored vitamin D over placebo for depressive symptoms (Hedges' g -0.317; 95% CI -0.405 to -0.230).
- The analysis combined general adult populations and clinical groups, so the overall estimate should not be treated as an individual treatment response.
- Between-study heterogeneity was high (I² 88.16%), and most trials raised risk-of-bias concerns.
- GRADE certainty was very low. The review did not establish a single depression-treatment dose or duration.